Danish Diabetes Drug Maker to Invest $78mln in Iran (FARS News Agency (Iran))

TEHRAN (FNA)- Novo Nordisk, the world’s largest diabetes drug maker, will invest up to $78.2 million (€70mln) to build an insulin manufacturing plant in Iran. “The plant is meant to produce a new generation of insulin in Iran,” Head of Food and Drug Administration of Iranian Health Ministry Rasoul Dinarvand said on the sidelines of a…

You May Also Like